Paul J. Tacken

4.0k citations

41 papers · 3.2k indexed · 1 hit paper · h-index 24

Co-authors: Carl G. Figdor Ruurd Torensma I. Jolanda M. de Vries Luis J. Cruz Remco Fokkink Gosse J. Adema Ben Joosten Cornelis J.A. Punt
Topics: Immunotherapy and Immune Responses (28 papers)T-cell and B-cell Immunology (17 papers)RNA Interference and Gene Delivery (13 papers)
Cited by: Immunology Pharmaceutical Science Oncology
Journals: SHILAP Revista de lepidopterologíaBlood Nature reviews. Immunology
Partner nations: Netherlands United States Spain

In The Last Decade

Paul J. Tacken

41 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting

2007 615 citations Paul J. Tacken, I. Jolanda M. de Vries et al. Nature reviews. Immunology profile →

Peers

Countries citing papers authored by Paul J. Tacken

Since Specialization

Citations

This map shows the geographic impact of Paul J. Tacken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul J. Tacken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul J. Tacken more than expected).

Fields of papers citing papers by Paul J. Tacken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul J. Tacken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul J. Tacken. The network helps show where Paul J. Tacken may publish in the future.

Co-authorship network of co-authors of Paul J. Tacken

This figure shows the co-authorship network connecting the top 25 collaborators of Paul J. Tacken. A scholar is included among the top collaborators of Paul J. Tacken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul J. Tacken. Paul J. Tacken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting Nanoparticles to Dendritic Cells for Immunotherapy 2012 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Luis J. Cruz,Paul J. Tacken,Félix Rueda,Joan Carles Domingo,Fernando Alberício,Carl G. Figdor	107
2	Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters 2012 ·Cancer Immunology Immunotherapy ·Erik H.J.G. Aarntzen,I. Jolanda M. de Vries,J Goertz,(unknown),(unknown),Mandy W.M.M. van de Rakt,Renate G. van der Molen,Cornelis J.A. Punt,Gosse J. Adema,Paul J. Tacken,Irma Joosten,Joannes F.M. Jacobs	19
3	The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells 2012 ·Blood ·Gerty Schreibelt,Lieke J.J. Klinkenberg,Luis J. Cruz,Paul J. Tacken,Jurjen Tel,Martin Kreutz,Gosse J. Adema,Gordon D. Brown,Carl G. Figdor,I. Jolanda M. de Vries	191
4	The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells 2011 ·Biomaterials ·Luis J. Cruz,Paul J. Tacken,Remco Fokkink,Carl G. Figdor	164
5	DEC‐205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells 2011 ·European Journal of Immunology ·Jurjen Tel,Daniel Benítez‐Ribas,(unknown),Alessandra Cambi,Gosse J. Adema,Carl G. Figdor,Paul J. Tacken,I. Jolanda M. de Vries	59
6	Targeted antigen delivery and activation of dendritic cells in vivo: Steps towards cost effective vaccines 2011 ·Seminars in Immunology ·Paul J. Tacken,Carl G. Figdor	103
7	Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity 2011 ·Blood ·Paul J. Tacken,Ingrid S. Zeelenberg,Luis J. Cruz,Maaike A Van Hout-Kuijer,(unknown),Remco Fokkink,Annechien J.A. Lambeck,Carl G. Figdor	147
8	Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro 2010 ·Journal of Controlled Release ·Luis J. Cruz,Paul J. Tacken,Remco Fokkink,Ben Joosten,Martien Cohen Stuart,Fernando Alberício,Ruurd Torensma,Carl G. Figdor	233
9	Activation of Human Plasmacytoid Dendritic Cells by TLR9 Impairs FcγRII-Mediated Uptake of Immune Complexes and Presentation by MHC Class II 2008 ·The Journal of Immunology ·Daniel Benítez‐Ribas,Paul J. Tacken,Cornelis J.A. Punt,I. Jolanda M. de Vries,Carl G. Figdor	23
10	No Advantage of Cell-Penetrating Peptides over Receptor-Specific Antibodies in Targeting Antigen to Human Dendritic Cells for Cross-Presentation 2008 ·The Journal of Immunology ·Paul J. Tacken,Ben Joosten,Anita Reddy,Dayang Wu,Annemarie Eek,Peter Laverman,Anke Kretz-Rommel,Gosse J. Adema,Ruurd Torensma,Carl G. Figdor	34
11	Dendritic-cell immunotherapy: from ex vivo loading to in vivo targetingbreakdown → 2007 ·Nature reviews. Immunology ·Paul J. Tacken,I. Jolanda M. de Vries,Ruurd Torensma,Carl G. Figdor	615
12	Internalizing Antibodies to the C-Type Lectins, L-SIGN and DC-SIGN, Inhibit Viral Glycoprotein Binding and Deliver Antigen to Human Dendritic Cells for the Induction of T Cell Responses 2006 ·The Journal of Immunology ·Naveen Dakappagari,Toshiaki Maruyama,Mark W. Renshaw,Paul J. Tacken,Carl G. Figdor,Ruurd Torensma,Martha A. Wild,Dayang Wu,Katherine S. Bowdish,Anke Kretz-Rommel	39
13	Monocyte CD64 or CD89 targeting by surfactant protein D/anti‐Fc receptor mediates bacterial uptake 2006 ·Immunology ·Paul J. Tacken,Joseph J. Batenburg	5
14	Targeting antigens to dendritic cells in vivo 2006 ·Immunobiology ·Paul J. Tacken,Ruurd Torensma,Carl G. Figdor	92
15	Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti–DC-SIGN antibody 2005 ·Blood ·Paul J. Tacken,I. Jolanda M. de Vries,Karlijn Gijzen,Ben Joosten,Dayang Wu,Russell P. Rother,Susan J. Faas,Cornelis J.A. Punt,Ruurd Torensma,Gosse J. Adema,Carl G. Figdor	219
16	Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus 2005 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Mitchell R. White,Erika C. Crouch,(unknown),Paul J. Tacken,Joseph J. Batenburg,Rikke Leth‐Larsen,Uffe Holmskov,Kevan L. Hartshorn	54
17	VLDL receptor deficiency enhances intimal thickening after vascular injury but does not affect atherosclerotic lesion area 2002 ·Atherosclerosis ·Paul J. Tacken,Dianne J. Delsing,Marion J. Gijbels,Paul H.A. Quax,Louis M. Havekes,Marten H. Hofker,Ko Willems van Dijk	22
18	Living up to a name: the role of the VLDL receptor in lipid metabolism 2001 ·Current Opinion in Lipidology ·Paul J. Tacken,Marten H. Hofker,Louis M. Havekes,Ko Willems van Dijk	59
19	Effective generation of very low density lipoprotein receptor transgenic mice by overlapping genomic DNA fragments: high testis expression and disturbed spermatogenesis 2001 ·Transgenic Research ·Paul J. Tacken,André van der Zee,Tim L. Beumer,Ralph J. Florijn,(unknown),Louis M. Havekes,Rune R. Frants,Ko Willems van Dijk,Marten H. Hofker	10
20	Modulating effects of thyroid state on the induction of biotransformation enzymes by 2,3,7,8-tetrachlorodibenzo-p-dioxin 1998 ·Environmental Toxicology and Pharmacology ·A. Gerlienke Schuur,Paul J. Tacken,Theo J. Visser,Abraham Brouwer	2

About Paul J. Tacken

Paul J. Tacken is a scholar working on Immunology, Molecular Biology and Virology, having authored 41 papers that have together received 3.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (28 papers), T-cell and B-cell Immunology (17 papers) and RNA Interference and Gene Delivery (13 papers). The work is most often cited by research in Immunology (2.4k citations), Pharmaceutical Science (155 citations) and Oncology (555 citations). Paul J. Tacken has collaborated with scholars based in Netherlands, United States and Spain. Frequent co-authors include Carl G. Figdor, Ruurd Torensma, I. Jolanda M. de Vries, Luis J. Cruz, Remco Fokkink, Gosse J. Adema, Ben Joosten, Cornelis J.A. Punt, Martin Kreutz and Ko Willems van Dijk. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Nature reviews. Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact